Target intelligence / Profile preview

Naïve B-cell receptor specific for Human Papillomavirus L1 conformational epitopes (HPV L1-specific BCR)

Target
HPV L1-specific BCR
Molecular classification
Receptor, Immunoglobulin, B-cell receptor complex
01

Overview

The naïve B-cell receptor (BCR) specific for Human Papillomavirus (HPV) L1 conformational epitopes is a membrane-bound immunoglobulin complex that serves as the primary recognition site for prophylactic HPV vaccines (Schiller & Lowy, 2012, Nat Rev Microbiol). These receptors are expressed on the surface of antigen-inexperienced B cells and are characterized by their high affinity for the three-dimensional arrangement of the L1 major capsid protein, which is presented in a highly repetitive manner on virus-like particles (VLPs) (Buck et al., 2013, J Virol). Upon binding to these conformational epitopes, the BCR undergoes cross-linking, which initiates downstream signaling through the Ig-alpha and Ig-beta subunits, leading to B-cell activation and the formation of germinal centers (Lowy & Schiller, 2006, J Clin Invest). This process results in the production of potent neutralizing antibodies that prevent the virus from binding to the basement membrane or entering host keratinocytes (Day et al., 2010, Structure). Prophylactic vaccines like Gardasil and Cervarix leverage this interaction to induce long-term protective immunity against high-risk HPV types, such as 16 and 18, which are responsible for the majority of cervical cancers (Harper et al., 2004, Lancet). The specificity of the BCR for conformational rather than linear epitopes is critical, as only antibodies against the intact capsid structure can effectively neutralize the virus in vivo (Christensen et al., 1996, J Virol).

Other names
HPV L1-specific B-cell receptorAnti-HPV L1 BCRB-cell receptor for HPV L1 VLPNaïve B-cell receptor for HPV major capsid protein
02

Mechanism of action

Vaccine-derived virus-like particles (VLPs) act as ligands that bind to and cross-link the B-cell receptors (BCRs) on naïve B cells, initiating signal transduction through the Ig-alpha/Ig-beta heterodimer that leads to B-cell activation, proliferation, and differentiation into long-lived plasma cells and memory B cells (Schiller & Lowy, 2012, Nat Rev Microbiol).

03

Biological functions

Immune responseAntigen recognitionB-cell activationSignal transductionHumoral immunity
04

Disease associations

InfectionCervical cancerAnal cancerOropharyngeal cancerAnogenital warts
05

Safety considerations

Injection site reactionsSyncopeHypersensitivityTheoretical risk of molecular mimicry
06

Interacting drugs

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

3 more in the full profile.

07

Biomarkers

Serum anti-HPV L1 IgG antibody titersHPV-specific memory B-cell frequencyNeutralizing antibody titers (VNP assay)

Beyond the preview

Go deeper on Naïve B-cell receptor specific for Human Papillomavirus L1 conformational epitopes (HPV L1-specific BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naïve B-cell receptor specific for Human Papillomavirus L1 conformational epitopes (HPV L1-specific BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call